Indonesia’s Ministry of Health and Philips to deliver nationwide coverage of advanced image-guided therapy systems in Indonesia, expanding access to cardiac, stroke and cancer care in all 38 provinces
Philips (NYSE: PHG) has secured landmark agreements with Indonesia's Ministry of Health to deploy advanced Azurion image-guided therapy systems across all 38 provinces.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Philips (NYSE: PHG) has secured landmark agreements with Indonesia's Ministry of Health to deploy advanced Azurion image-guided therapy systems across all 38 provinces. This nationwide initiative, part of the Strengthening Indonesia's Healthcare Referral Network (SIHREN) project, aims to transform treatment for heart disease, stroke, and cancer through minimally invasive care.
The project addresses healthcare accessibility challenges in Indonesia, the world's fourth most populous nation with over 280 million people spread across 17,000+ islands. The initiative comes as Indonesia faces rising non-communicable diseases projected to cost USD 4.47 trillion. Philips, employing over 3,900 people across 12 Indonesian cities, won the contract through an international competitive bidding process.
Positive
- None.
Negative
- Significant infrastructure and training challenges in implementing systems across 17,000+ islands
- High economic burden of USD 4.47 trillion from non-communicable diseases indicates substantial healthcare costs
Details
News Market Reaction – PHG
The recorded move for PHG in the trading session of this news was +9.20%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
July 29, 2025
- Long-term multiyear agreements will see Philips installing its advanced Azurion image-guided therapy systems nationwide across all provinces, including rural and remote areas
- Initiative brings minimally invasive care to millions of cardiac, stroke and cancer patients in Indonesia
- Combines cutting-edge treatment technology, services and training to strengthen Indonesia’s health infrastructure
Amsterdam, the Netherlands and Jakarta, Indonesia – In a major step toward transforming healthcare delivery, Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology and the Indonesia’s Ministry of Health today announced plans to deploy state-of-the-art image-guided therapy systems nationwide, as part of their signed agreements, under the Strengthening Indonesia’s Healthcare Referral Network (SIHREN) project.
The landmark agreements, recently awarded to Philips after an international, competitive bidding process, combine cutting-edge treatment technology, services and training to strengthen Indonesia’s health infrastructure. The initiative aims to transform the country’s treatment for heart disease, stroke and cancer – Indonesia’s leading causes of death – by expanding access to cutting-edge technologies and care in all 38 provinces, from Aceh to Papua. This initiative is set to benefit millions of patients across Indonesia.
The SIHREN project is an ambitious effort jointly funded by the World Bank and other multilateral development banks to support Indonesia’s health transformation agenda by significantly improving referral healthcare.
Challenges in ensuring equitable access to healthcare
With a population exceeding 280 million, Indonesia is the world’s fourth most populous nation. As a vast archipelago of over 17,000 islands, it faces significant challenges in ensuring equitable access to healthcare. The country is also grappling with a surge in non-communicable diseases (NCDs) such as heart disease, stroke and cancer – conditions projected to impose a staggering economic burden of USD 4.47 trillion [1]. And yet, advanced care for these illnesses remains largely centralized on the densely populated island of Java, leaving much of the country underserved.
The initiative will establish a nationwide network of advanced image-guided therapy rooms, dramatically expanding access to minimally invasive treatments across hundreds of hospitals in all 38 provinces. The Ministry of Health has made a long-term commitment to delivering nationwide coverage of the Azurion platform, aligned to local hospital infrastructure and patient population needs.
A study published in the Journal of Minimally Invasive Surgery [2] found that minimally invasive techniques significantly reduce postoperative pain, recovery time, and hospital stays compared to traditional open surgeries.
"Delivering better care for more people requires strong partnerships and the best innovations,” said Roy Jakobs, CEO of Royal Philips. “We’re honored to be Indonesia’s partner of choice to deliver our innovation directly where it's needed most. More patients in Indonesia will now have access to better care.”
“Minimally invasive care is life-changing for patients, unlocking treatment options that were once unimaginable. With small incisions, such targeted treatments can mean shorter hospital stays, fewer complications and quicker recoveries for patients,” said Carla Goulart Peron, Chief Medical Officer at Philips. “From opening heart-attack-causing blockages, to treating strokes and targeting cancer tumors, image-guided, minimally invasive therapy will be a game-changer for NCD care in Indonesia.”
Philips maintains a strong footprint in Indonesia, employing over 3,900 people across 12 cities and operating a manufacturing facility in Batam for its Personal Health businesses. The Philips Foundation recently launched a major partnership with World Child Cancer to advance early detection of childhood cancers across the country.
“We remain committed to supporting healthcare transformation by delivering innovations that provide better outcome for patient and improve experience for healthcare workers,” said Astri R. Dharmawan, President Director of Philips Indonesia. “Our combined efforts with the Indonesian government will help close healthcare gaps and bring us closer to a Healthy Indonesia.”
[1] https://www3.weforum.org/docs/WEF_The_Economics_of_non_Disease_Indonesia_2015.pdf
[2] https://pubmed.ncbi.nlm.nih.gov/14746519/
For further information, please contact:
Michael Fuchs
Global External Relations Director, Philips
Tel.: +31 614 869 261
E-mail: michael.fuchs@philips.com
Jane Yeo
Head of Brand and Communications APAC, Philips
Tel.: +65 9618 7397
E-mail: jane.yeo@philips.com
About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people’s health and well-being through meaningful innovation. Philips’ patient- and people-centric innovation leverages advanced technology and deep clinical and consumer insights to deliver personal health solutions for consumers and professional health solutions for healthcare providers and their patients in the hospital and the home.
Headquartered in the Netherlands, the company is a leader in diagnostic imaging, ultrasound, image-guided therapy, monitoring and enterprise informatics, as well as in personal health. Philips generated 2024 sales of EUR 18 billion and employs approximately 67,300 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter.
Attachments
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.